Cancer expert Dr. Robert Winn talks about the importance of discussing
biomarker testing as soon as possible, even before getting a definitive diagnosis of
non-small-cell lung cancer. Patients should also ask about removing additional tissue or repeating biomarker testing if samples are taken, in order to yield the most accurate results. Dr. Winn encourages patients to take advantage of
precision medicine to receive lung cancer treatments tailored to their specific mutations.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.